Household air pollution (HAP) attributed to wood use is a potential environmental risk factor for lung cancer, to which ~2.5 billion people worldwide (including >15 million in the US) are exposed. Known lung cancer risk factors (i.e., environmental tobacco smoke (ETS), outdoor air pollution (OAP), family history) do not fully account for the disease burden. To reach robust conclusions about biomass's pulmonary carcinogenicity and the lung cancer deaths attributed to HAP while accounting for confounding exposures, prospective studies of individuals experiencing a variety of exposure levels of HAP, ETS, and other suspected lung carcinogens are needed. We will leverage our global consortium of prospective studies (HAPCO: Household Air Pollution Cohorts), which is a pooled resource of >550,000 subjects, to for the first time accurately quantify the relative risk of lung cancer mortality associated with wood use. Further, we will estimate time-dependent population-attributable fraction (PAF) function for lung cancer mortality, which will measure the potential reduction in lung cancer mortality if HAP is eliminated or reduced while adjusting for known and suspected lung carcinogens (i.e., ETS, OAP). Our robust harmonization of HAP data will also provide the unique opportunity to determine the relative and absolute risks associated with HAP exposures for cancers other than lung cancer, which was recently highlighted by an expert panel convened by multiple US Federal Agencies.

Public Health Relevance

We are uniquely positioned to study pivotal questions relating to the adverse health effects of household air pollution (HAP), including (1) if biomass (i.e., wood) use is associated with lung cancer mortality, and (2) if HAP is associated with increased risk of cancers other than lung cancer. Using 13 cohort studies for a combined sample size of >550,000 subjects, we will be the first to prospectively evaluate cancer site-specific mortality and HAP. Our findings will inform policies and regulations designed to reduce the global burden of HAP-associated disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01CA242740-01A1
Application #
10053367
Study Section
Cancer, Heart, and Sleep Epidemiology A Study Section (CHSA)
Program Officer
Lai, Gabriel Y
Project Start
2020-09-02
Project End
2023-08-31
Budget Start
2020-09-02
Budget End
2021-08-31
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
081266487
City
Bronx
State
NY
Country
United States
Zip Code
10461